Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Dienogest for Ovarian Endometrioma
NCT02728245Phase 2Withdrawn
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dienogest in ovarian endometrioma, sponsored by Seoul National University Hospital. Planned start Oct 2017; status: withdrawn.
02
Drugs
dienogest
03
Conditions
ovarian endometrioma
Beyond the preview
Go deeper on NCT02728245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728245.